Like most websites, we use cookies and other similar technologies for a number of reasons, such as keeping our website reliable and secure, personalizing content, providing social media features and to better understand how our site is used. By using our site, you are agreeing to our use of these tools. Please review our Privacy Policy to learn more. 

Skip to Content

For everyone's safety, masks are required for everyone in our facilities. This includes visitors and patients (except in special circumstances).

View new visitor guidelines, effective August 31.

Past Residents

Learn about past residents and their experiences at Bryan Health

Drew Klick, PharmD, MBA, BCPS 

Education & Residency Project:

  • Creighton University School of Pharmacy and Health Professions, Class of 2015
  • Bryan Health Residency Class, of 2016
  • Residency Project: A retrospective analysis of fixed vs. weight-based dosing of four-factor prothrombin complex concentrate. This was a single-center study that compared the outcomes of two methods of 4F-PCC dosing. The majority of patients were on warfarin for CVA prophylaxis and requiring reversal due to active bleeding on presentation. In actively bleeding patients, fixed & weight-based dosing were equally effective at reversing bleeding. 

Current Area of Practice/Position: 

Clinical pharmacist at the University of Minnesota Fairview St. Joseph's Hospital. I work primarily in the emergency department and intensive care units.

Why Bryan Health?

Bryan Health has a variety of opportunities to grow as a pharmacist. My areas of interest after graduation were critical care and trauma.  I had the opportunity to work in multiple critical care areas including neuro/trauma ICU, med/surg ICU, and cardiac ICU. Bryan also provided the chance to grow in areas like mental health and long-term care.


Keely Hamann, PharmD, BCPS

Education & Residency Project:

  • South Dakota State University, College of Pharmacy, Class of 2015
  • Bryan Health Residency, Class of 2017
  • Residency Project: Evaluation of insulin infusion protocol for diabetic ketoacidosis and hyperosmolar hyperglycemic state at a community hospital. Evaluation of the current protocol for treatment of DKA and HHS, specifically with insulin infusion, with the intent to identify issues/shortcomings of the protocol in order to improve patient outcomes and minimize adverse effects of insulin infusion therapy.

Current Area of Practice/Position: 

Clinical pharmacist in the Bryan Medical Center. I work in the ICU, primarily neurotrauma ICU.

Why Bryan Health?

Bryan provided the opportunity to explore different aspects of inpatient clinical pharmacy and then to focus in on my areas of interest. 


Katie Thompson, PharmD

Education & Residency Project:

  • Creighton University School of Pharmacy and Health Professions, Class of 2017
  • Bryan Health Residency, Class of 2018
  • Residency Project: Evaluated the effect of pharmacist directed, chronic obstructive pulmonary disease guideline-directed inhaler therapy on discharge. I was able to coordinate proper guideline-directed inhaler regimens with the pulmonary team and COPD educator for patients with COPD in attempt to decrease hospital readmissions.

Current Area of Practice/Position: 

Clinical pharmacist at CHI Health Creighton University Medical Center, Bergan Mercy

Why Bryan Health?

I chose Bryan for the ability to personalize my rotations and experience, but I really enjoyed my time due to the close-knit pharmacy staff. My time at Bryan definitely prepared me to be a hospital pharmacist.


Ryan Zwick, PharmD

Education & Residency Project:

  • University of Kansas School of Pharmacy, Class of 2018
  • Bryan Health Residency, Class of 2019
  • Residency Project: Pharmacist led stress ulcer prophylaxis management in the ICU. Inappropriate stress ulcer prophylaxis inside and outside of the intensive care unit has been an ongoing problem leading to new acid suppression therapy prescriptions upon hospital discharge. My residency research project was a dual retrospective review of new acid suppression therapy prescriptions being continued on intensive care unit discharge to floor and hospital discharge after implementation of a pharmacist managed stress ulcer prophylaxis pilot study. My research study concluded that a pharmacist-managed SUP procedure leads to significantly decreased rates of acid suppression therapy orders continued upon ICU discharge to floor, decreased new acid suppression therapy prescriptions upon hospital discharge, and reduced rates of proton pump inhibitor use for stress ulcer prophylaxis. This research study has resulted in a pharmacist managed stress ulcer prophylaxis procedure to start and stop acid suppression therapy for stress ulcer prophylaxis in the three critical care units.

Current Area of Practice/Position: 

Bryan Medical Center clinical pharmacist. I work on the internal medicine and critical care teams.

Why Bryan Health?

A major reason that I came to Bryan for residency and stayed at Bryan after residency was the providers. The providers are pharmacy friendly and appreciate any help that the pharmacists can provide.


Amy Venteicher, PharmD

Education & Residency Project:

  • University of Nebraska Medical Center College of Pharmacy, Class of 2018
  • Bryan Health Residency, Class of 2020
  • Residency Project: Incidence of heparin induced thrombocytopenia (HIT) in patients following cardiac surgeries. Following cardiac procedures such as a valve replacement or a CABG, patients often experience a transient drop in platelets which leads to fear of HIT and initiation of Argatroban, a non-heparin anticoagulant. Current data cites the incidence of true HIT as <1% in this patient population. My project is designed to determine the incidence of HIT in patients following a cardiac procedure and provide education following the project’s conclusion.

Why Bryan Health?

I enjoy working with the other pharmacists on a daily basis. Everybody is incredibly kind and willing to answer any questions I have. 


Adam Goetz, PharmD

Education & Residency Project:

  • South Dakota State University, Class of 2019
  • Bryan Health Residency, Class of 2020
  • Residency Project: Incidence of hyperchloremic metabolic acidosis in patients receiving 0.9% sodium chloride vs. buffered saline solution (Plasmalyte-ATM, Normosol-RTM) for sepsis in the ICU. In comparison to sodium chloride, buffered solutions have been associated with reduced rates of hyperchloremic metabolic acidosis, acute kidney injury (AKI), mechanical ventilation, and in-hospital mortality. Compared to crystalloids, colloid solutions are presumptively more efficient when comparing the amount of fluid retained within the intravascular compartment, which achieves similar hemodynamic stability with less fluid requirements. The purpose of this study is to determine the effect of buffered sodium chloride solutions when compared with 0.9% sodium chloride on the outcomes of acute kidney injury with fluid replacement in sepsis resuscitation and maintenance fluid administration.

Why Bryan Health?

Bryan’s residency program provides opportunities in many areas of the hospital, which opens doors to new experiences and interests (e.g. internal medicine, cardiac ICU, medical ICU, neurotrauma ICU, behavioral health, and many others).


Nikki Owen, PharmD

Education & Residency Project:

  • Creighton University School of Pharmacy and Health Professions, Class of 2019
  • Bryan Health Residency, Class of 2020
  • Residency Project: Implementation of a venous thromboembolism prophylaxis protocol for traumatic brain injury patients.

Why Bryan Health?

Bryan has outstanding interdisciplinary rapport which provides a supportive environment for learning and personal and professional growth.


Marysa Wilson, PharmD

Education & Residency Project:

  • University of Nebraska Medical Center, Class of 2019
  • Bryan Health Residency, Class of 2020
  • Residency Project: Extended-infusion versus intermittent-infusion cefepime in the treatment of microbiologically-confirmed infections. This study will evaluate the impact of extended infusions of cefepime on when compared with traditional intermittent infusions. Outcomes include rates of clinical cure, ICU length of stay, duration of mechanical ventilation, hospital readmission rates, and development of drug resistance and secondary superinfection.  

Top

Copyright 2021 Bryan Health. All rights reserved.